P/E ratio for Global Blue Group (GB)
P/E ratio as of June 2024 (TTM): < -1000
According to Global Blue Group's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1749.73. At the end of 2022 the company had a P/E ratio of -16.8.
P/E ratio history for Global Blue Group from 2020 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -16.8 | 66.64% |
| 2021 | -10.1 | 100.04% |
| 2020 | -5.05 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 10.3 | -100.59% | 🇺🇸 USA |
 Medtronic MDT | 30.0 | -101.72% | 🇮🇪 Ireland |
 Boston Scientific BSX | 93.9 | -105.36% | 🇺🇸 USA |
 Edwards Lifesciences EW | 37.3 | -102.13% | 🇺🇸 USA |
 Stryker Corporation SYK | 50.4 | -102.88% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.